ABSTRACT
INTRODUCTION
Upper gastrointestinal complaints or dyspepsia syndrome is common indiabetic patients. 1 Various studies show that the prevalence of dyspepsia in diabetics patients ranges between 30-60%. [1] [2] [3] [4] Theory which explains the occurrence of dyspepsia and peptic ulcer syndrome is the theory of balance between aggressive factors and defensive factors. 5, 6 Due to the imbalances between those factors, will occur dyspepsia in mucous, submucous, until the muscle layer of the upper gastrointestinal tract. 5 In connection with the imbalance theory between aggressive factors and defensive factors, in diabetes mellitus (DM) patients is predicted occur interference in defensive factors, in form of delayed gastric emptying (gastroparesis). 6, 7 The prevalence of gastroparesis in type 1 diabetes ranges between 27-58%, whereas in type 2 diabetes ranges between 30-60%. 7, 8 There is a tendency of reduction in gastric acid secretion in patients with DM who are already experiencing gastroparesis and autonomic neuropathy complications. Because of the limitation of this study, the measurement of gastric retention (gastroparesis) are not done but replaced with microalbuminuria measurement. Based on theory, mechanism of gastric retention (gastroparesis) and microalbuminuria in diabetic patients is through the same pathway, which is chronic hyperglycemia.
Results of several studies on gastric acid in diabetic patients are not always consistent. Parkman et al found that there is a reduction in gastric acid peak secretion after tetragastrin stimulation in diabetic patients with autonomic neuropathy. 9 Sasaki et al, Meler et al found that gastric acid secretion because of stimulation is commonly found in type 2 diabetes patients. 10, 11 Tashima et al, Nabavizadeh et al found in their studies in experimentally induced diabetic rats that gastric acid secretion showed varied results.
12,13 Nakamura et al found that there is a decrease in gastric acid secretion in diabetic patients with autonomic neuropathy.
14 Latest study by Hasler et al found that gastric acid secretion will be decreased in diabetic patients with gastroparesis compared with healthy controls, and gastric acid secretion lower in moderate-severe gastroparesis compared with mild gastroparesis. 15 The problem of this study is while dyspepsia syndrome often seen in diabetic patients, previous studies about gastric acidity in diabetic patients did not give similar results. Research with method of measuring gastric pH in the stomach of dyspepsia patients with DM has never been done in Indonesia. The aims of this study are to know whether there is any difference in gastric pH in dyspepsia patients with DM and those without DM, whether there is any correlation between gastric pH with severity of diabetic complications which measured by microalbuminuria, and whether there is any correlation between gastric pH with the control of blood glucose levels which measured by HbA1c.
METHOD
This study design was cross sectional study. This study aimed to determine the average of basal gastric pH in two unpaired groups (dyspepsia patients with diabetic vs. dyspepsia patients without diabetics) and to determine whether there is any correlation between gastric pH with microalbuminuria and HbA1c in dyspepsia patients with diabetic group.
The study was conducted on outpatients and inpatients in Internal Medicine Department of Regional Samples recruited with consecutive sampling from outpatients and inpatients in Division of Internal Medicine, Regional General Hospital Nagan Raya Aceh. Then, the anamnesis or medical history (age, sex, duration of DM and dyspepsia complaint) was taken. Before the study, drugs which suppresse or neutralize gastric acid was stopped. Proton pump inhibitor (PPI) drugs must be stopped 7 days before, H2 receptor antagonist drugs must be stopped 2 days before, and antacid drugs must be stopped 1 days before. Afterwards, pH metri, endoscopy, microalbuminuria, and HbA1c test were done on the patients.
Data was processed using software, data analysis to and to see the difference in basal gastric pH between the two groups was done using Chi-square test. Data analysis for the second and third hypotheses was done using correlation test. Test results with p < 0.05 were were processed using SPSS.
RESULTS
During the period of study, 60 dyspepsia patients were involved in the study. Of the 60 dyspepsia patients, there are 30 patients are diabetic patients, while the remaining 30 patients are non-diabetic patients. All of the 60 patients underwent endoscopic examination of the gastrointestinal tract and basal gastric pH. Furthermore, the 30 dyspepsia patients with DM also underwent microalbuminuria and HbA1c tests. Characteristics of 60 dyspepsia patients with DM and without DM who participated in the study are as follows: Before the data analysis, the normality test was done using Kolmogorov-Smirnov test and Shapiro-Wilk test in both study groups. Results of normality test results showed that the data are not normally distributed. Because the data was not normally distributed, then data transformation was done in order to normalize the data, but the result of data transformation is still not normally distributed. Therefore, the data analyzed using the comparative test of unpaired data with MannWhitney test.
Results The results of this study found that basal gastric pH was 2.30 ± 0.83 for dyspepsia patients with DM and 2.19 ± 0.52 for dyspepsia patients without DM. The results obtained in this study found that gastric pH was higher in dyspepsia patients with DM than in dyspepsia patients without DM. Previous study that in accordance with this results is study from Hasler et al, who found that basal gastric pH in dyspepsia patients with DM was higher than basal gastric pH in dyspepsia patients without DM. Basal gastric pH in dyspepsia patients with DM was 3.64 ± 0.41 and basal gastric pH in dyspepsia patients without DM was 1.90 ± 0.18. In the Hasler study, it was obtained basal gastric pH higher (3.64 ± 0.41) than those in this study (2.30 ± 0.83). In Hasler study, it was turned out that all DM patients who participated in the study had experienced neuropathy complications in the form of gastric retention (diabetic gastroparesis).
Gastric acid secretion is regulated by two mechanisms: neuropathic factors and non-neuropathic factors. In several studies, prandial gastric acid secretion will decreased in 2/3 diabetic patients, which indicates a disruption of the vagus nerve response (neuropathy factor). 4, 15 Beside the neuropathy factors, the nonneuropathy factors also contribute to impairment of gastric acid secretion, for example: gastric retention and parietal cells antibodies. 15, 16 Gastric retention is a nonfactor neuropathy associated with impaired secretion of gastric acid in diabetic patients. Although gastric retention contributed to impaired gastric secretion, the gastric retention itself was caused by autonomic neuropathy factor. A correlation study between gastric acidity with severity of gastric retention in diabetes, found increase in basal and post prandial pH that in line with severity of gastric retention. 15 This study examined basal gastric acid secretion in diabetic and non-diabetic group, which found basal gastric pH was 2.30 ± 0,83 in diabetic group and 2.19 ± 0,52 in non-diabetic group. Study from Hasler et al found that basal gastric pH in diabetic group was 3.64 ± 0,41 and basal gastric pH was 1,90 ± 0,18. With cut-off dyspepsia with diabetes group and dyspepsia without diabetes group. This result is same as result from Hasler 
DISCUSSION
Secretion of gastric acid will decreased by itself in diabetic patients because of the diabetic factors itself (neuropathy factor) and also because of gastric retention, anti-parietal cell antibodies, gastric distension (non-neuropathy factor). 15 Several studies those conducted before found that acid secretion both basal and prandial will be decreased in diabetic patients compared to non-diabetic patients. 4, 15 In this study, examination of acid secretion was done by measuring the gastric pH of the dypepsia patients. Gastric pH of dyspepsia patients with DM was compared to dyspepsia patients without DM. In this study, we just measured the basal gastric pH and not the prandial gastric pH. Basal gastric pH was measured by measuring the intra-gastric pH, which measures the pH directly into the lumen through the probe which inserted into the lumen of the stomach. Several previous studies as was done by Parkman et al and Nakamura et al found that gastric acid secretion decreased in diabetic patients who have experienced autonomic neuropathy complications. Whereas Meier et al found different results, which is there is no difference in gastric acid secretion in diabetic patients and normal subjects. On this study, the subject have not experienced diabetic autonomic neuropathy. 9, 14, 15 In this study because of several limitations, gastric retention was not measured, but instead microalbuminuria measured. Gastric retention and microalbuminuria are late state diabetes' complications. Mechanisms of gastric retention and microalbuminuria are similar, which caused by microangiopathy. 15, 17, 18 In previous studies, it was found that the severity of the gastric acid secretion declining is in line with severity of gastric retention. In this study, the severity of microalbuminuria did not describe the severity of gastric retention, but only illustrate the severity of diabetes complications. This study measured microalbuminuria. Microalbuminuria is a sign of systemic endothelial dysfunction. In this study, microalbuminuria is used as a marker for diabetes patients who are already experiencing complications.
correlation between microalbuminuria and basal gastric pH. These data indicated that the impairment of acid secretion in patients with DM is correlated with the severity of diabetes complications that occur. This is consistent with Hasler et al study, which found that the gastric acid secretion in DM decreased in line with increasing severity of gastric retention. 15 However, some early studies found normal gastric acid secretion in diabetic patients, as in studies conducted by Sasaki et al and Meier et al. This is possible due to diabetic patients who studied by Sasaki and Meier are the diabetic patients who have not developed any complications such as autonomic neuropathy and gastroparesis. 10, 11 This study also assessed the blood glucose control in the past 3 months through HbA1c, which later not found any correlation between levels of poor blood glucose control with basal gastric acid secretion impairment. It can be explained that the impairment of gastric acid secretion is associated with complications of the diabetes itself, whereas HbA1c does not describe the severity of complications of DM.
From the results of this study, we found several important things, which are: 1) The gastric pH in dyspepsia patients without DM; 2) The management of dyspepsia patients is based on the balance theory of aggressive factors and defensive factors, therefore management of dyspepsia-DM is still to control aggressive factors and to increase defensive factors, this is due to even though there was an increasing gastric pH in diabetic group, it was not too high; 3) In the population of diabetic patients in Nagan Raya Aceh, it was found that basal gastric pH 2.02 is the limit for the occurrence of gastric secretion impairment in diabetic patients.
Some of the limitations in this study are gastric retention, which is a complication of DM that directly caused dyspepsia complaints, was not examined, and although in this study the gastric retention examination replaced by measuring microalbuminuria, because the similar pathophysiological mechanisms of gastric retention and microalbuminuria is through the same pathway. Furthermore, many factors were not evaluated in this study such as autonomic neuropathy, dyspepsia complaints, Helicobacter pylori, therefore the results of this study can not be generalized generally.
CONCLUSION
From the results of this study, the basal gastric pH on dyspepsia patients with DM was 2.30 ± 0.83, whereas in dyspepsia patients without DM was 2.19 ± 0.52. This research also found that when the basal gastric pH is 2.02, then it impairment on gastric acid secretion is already happened in dyspepsia patients with DM. Further research is needed which connects the gastric pH with gastroparesis, autonomic neuropathy, and dyspepsia complaints.
